New capability allows brands to generate thousands of personalized event invitations from existing video libraries ...

I open my emails to find yet another message from a patient about their amphetamine-dextroamphetamine (the generic form of Aderall) no longer working. Dr. Plutchik, my meds no longer seem to be ...

Modular electric guitars are the future of the iconic instrument We're coming up on the 100th anniversary of the electric guitar, and it's been fascinating to hear how this simple instrument has ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Albertans may see more and less-expensive varieties of Ozempic on the market soon, after a patent on the drug expired two weeks ago. Ozempic has made headlines in recent years as a popular weight-loss ...

But a ProPublic investigation found that the FDA rarely tests the quality of generic drugs, many of them manufactured overseas. National reporter Debbie Cenziper of ProPublica was one of the authors ...

On January 8, 2026, Collegium Pharmaceutical, Inc. issued full-year 2026 guidance, projecting US$805 million to US$825 million in net product revenues and highlighting new authorized generic supply ...

Vyvanse, or its generic counterpart lisdexamfetamine dimesylate, is prescribed to treat ADHD in adults, and children six years of age or older, as well as moderate to sever binge eating disorder (BED) ...

The Food and Drug Administration (FDA) is launching an effort to streamline the approval process for cheaper alternative “biosimilar” versions of biologic drugs as a way to curb health costs. The ...

The Food and Drug Administration said it will take steps to speed up the process of developing generic versions of complex biological drugs, in a bid to increase cheaper competition for expensive ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Forbes contributors publish independent expert analyses and insights. The U.S. spent $722.5 billion on pharmaceuticals in 2023. Although brand-name drugs consume four out of every 5 dollars America ...